Why Grace Therapeutics, Inc.’s (GRCE) Stock Is Up 6.03%
As of Thursday, April 23, Grace Therapeutics, Inc.’s GRCE share price has surged by 6.03%, which has investors questioning if this is right time to sell.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Rosalio Madrigal
Tudor Pop
Jenna Brashear
Cynthia McLaughlin
| Share Statistics | GRCE | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $36.4 | $421.0 | 15% |
|
| Shares Out (Mil) | 20.1 | 46.5 | 30% |
|
| Institutional Ownership | 57.9% | 82.0% | 38% |
|
| Float (Mil) | 13.3 | 48.3 | 23% |
|
| Beta | na | 0.68 | na |
|
| Avg Daily Volume (000s) | 74 | 348 | 32% |
|
| Price Change (52-week) |
(42.3%) | 52.0% | 23% |
|
| Growth | GRCE | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 6.6% | na |
|
| Net Income (5yr) | 16.9% | (1.6%) | 68% |
|
| EPS (5yr) | 43.2% | 15.1% | 90 |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | (15.1%) | (15.1%) | 51% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 1 | 1 | |
| Current EPS | ($0.145) | ($0.532) | ($0.416) | |
| Month Ago EPS | ($0.145) | ($0.532) | ($0.447) | |
| # Rev Up | 0 | 0 | 1 | |
| # Rev Down | 1 | 1 | 0 | |
| Three Months Ago EPS | ($0.145) | ($0.532) | ($0.447) | |
| Year/Year Chg | 36.8% | 12.7% | na | |
| Financials | GRCE | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $289 | na |
|
| Net Income (TTM) (Mil) | ($21) | ($11) | 23% |
|
| EPS (TTM) | ($1.196) | ($0.600) | 19% |
|
| Operating Cash Flow (TTM) (Mil) | ($9) | ($7) | 21% |
|
| Net Cash Flow (TTM) (Mil) | na | $1 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $4 | 0% |
|
| Enterprise Value (Q1) (Mil) | $17 | $331 | 11% |
|
| Valuation | GRCE | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.66 | 2.27 | 16% |
|
| P/E | na | 24.1 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.2 | na |
|
| Ratios | GRCE | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 69.4% | na |
|
| Net Margin | na | 3.9% | na |
|
| ROA | (34.5%) | (23.8%) | 15% |
|
| ROE | (36.2%) | (24.7%) | 18% |
|
| Liabilities to Assets | 3.8% | 32.0% | 2% |
|
| F-Score | 1 | 3 | 1% |
|
Passing Stock Screens
As of 11/18/2026, from a list of 60 stock screening strategies,
| Performance Since Inception: | 2.6% |
| +/- S&P 500: | -4.8 |
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors